2019 Round Table

Pharmacoeconomy & risk sharing contracts

2019 pharmacoeconomy

How to honour the country promise to its citizens, ie access to universal free healthcare to all algerian citizens, considering the current resource.

Importance to define an organisation for healthcare & having clear objectives for the implementations of the contracts :
- The contrats can be signed with the industry Or organisation/consortium/group of companies.

Identify and explain the notion of performance and risk: - What type of performance are we measuring?
- What are the evaluation criteria & parameters?
- Which efficiency biomark are implemented?
- Which KPIs are clinically relevant?
- The expected benefits


Attending Experts

Phillippe Megerlin

University of Strasbourg

Dr. Filipo Drago

University of Catania